Generics in Global Antivirals Market Forecast to Reach $9.2 Billion by...

Research and Markets Announces the Addition of GBI's Research "Generics in the Antivirals Market to 2018 - Launch of Generic Combivir and Patent Expiry of Sustiva, Kaletra and Epivir-HBV will...(PRWeb February 14, 2013)Read the full story at http://www.prweb.com/releases/2013/2/prweb10433563.htm
Source: PRWeb: Medical Pharmaceuticals - Category: Pharmaceuticals Source Type: news